ES8704504A1 - Un procedimiento para preparar isomeros opticamente activos de dioxafosforinanos - Google Patents

Un procedimiento para preparar isomeros opticamente activos de dioxafosforinanos

Info

Publication number
ES8704504A1
ES8704504A1 ES554328A ES554328A ES8704504A1 ES 8704504 A1 ES8704504 A1 ES 8704504A1 ES 554328 A ES554328 A ES 554328A ES 554328 A ES554328 A ES 554328A ES 8704504 A1 ES8704504 A1 ES 8704504A1
Authority
ES
Spain
Prior art keywords
dioxaphosphorinanes
optically active
preparation
active compounds
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554328A
Other languages
English (en)
Other versions
ES554328A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OCE-Andeno BV
Oce Andeno BV
Original Assignee
OCE-Andeno BV
Oce Andeno BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OCE-Andeno BV, Oce Andeno BV filed Critical OCE-Andeno BV
Publication of ES554328A0 publication Critical patent/ES554328A0/es
Publication of ES8704504A1 publication Critical patent/ES8704504A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ISOMEROS OPTICAMENTE ACTIVOS DE DIOXAFOSFORINANOS, DE FORMULA (I). CONSISTE EN LA REACCION DEL RACEMATO DE UN COMPUESTO DE FORMULA (I), EN LA QUE M ES HIDROGENO ION METALICO O AMONIO Y R1-R4 PUEDEN SER VARIOS TIPOS DE RADICALES, CON UN COMPUESTO AMINO OPTICAMENTE ACTIVO, EN UN DISOLVENTE INERTE; SEPARACION DE LAS SALES DIASTEREOMERAS CRISTALINA Y DISUELTA; E HIDROLISIS DE UNA Y OTRA SAL. ESTOS COMPUESTOS TIENEN APLICACIONES PARA LA RESOLUCION DE RACEMATOS DE COMPUESTOS DE AMINO.
ES554328A 1984-10-24 1986-04-24 Un procedimiento para preparar isomeros opticamente activos de dioxafosforinanos Expired ES8704504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8403224A NL8403224A (nl) 1984-10-24 1984-10-24 Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.

Publications (2)

Publication Number Publication Date
ES554328A0 ES554328A0 (es) 1987-04-01
ES8704504A1 true ES8704504A1 (es) 1987-04-01

Family

ID=19844654

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548135A Expired ES8701187A1 (es) 1984-10-24 1985-10-23 Un procedimiento para preparar dioxafosforinanos
ES554328A Expired ES8704504A1 (es) 1984-10-24 1986-04-24 Un procedimiento para preparar isomeros opticamente activos de dioxafosforinanos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES548135A Expired ES8701187A1 (es) 1984-10-24 1985-10-23 Un procedimiento para preparar dioxafosforinanos

Country Status (6)

Country Link
US (1) US4814477A (es)
EP (1) EP0180276B1 (es)
JP (1) JPH0662652B2 (es)
DE (1) DE3567022D1 (es)
ES (2) ES8701187A1 (es)
NL (1) NL8403224A (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
WO1999045016A2 (en) 1998-03-06 1999-09-10 Metabasis Therapeutics, Inc. Novel prodrugs for phosphorus-containing compounds
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
WO2000052015A2 (en) 1999-03-05 2000-09-08 Metabasis Therapeutics, Inc. Novel phosphorus-containing prodrugs
ATE320420T1 (de) 1999-10-22 2006-04-15 Takeda Pharmaceutical Verfahren zur herstellung von optisch aktiven naphthalinderivaten und darin eingesetzte optische resolver
WO2001034557A1 (fr) * 1999-11-10 2001-05-17 Takeda Chemical Industries, Ltd. Procede de production de derives d'enaminone cycliques optiquement actifs
SK287188B6 (sk) 1999-12-10 2010-02-08 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidínová zlúčenina, jej použitie a farmaceutická kompozícia alebo kombinácia s jej obsahom
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR20030036189A (ko) 2000-05-26 2003-05-09 이데닉스(케이만)리미티드 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
CA2432410A1 (en) * 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Process for preparing optically active 2,3-dihydro- benzofuran compounds
US7301023B2 (en) * 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
WO2003026589A2 (en) 2001-09-28 2003-04-03 Idenix (Cayman) Limited Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
EP1504014B1 (en) 2002-05-13 2015-12-02 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of pmea and pmpa
AU2003299492B2 (en) 2002-05-13 2010-06-10 Metabasis Therapeutics, Inc. Cyclic prodrugs of PMEA one of its analogues
AU2003248748A1 (en) * 2002-06-28 2004-01-19 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
DE14169110T1 (de) 2002-06-28 2022-05-12 Centre National De La Recherche Scientifique -Cnrs- Modifizierte 2'- und 3'-Nukleosid-Prodrugs zur Behandlung von Flaviridae-Infektionen
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
US7148349B2 (en) 2002-10-31 2006-12-12 Metabasis Therapeutics, Inc. Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
KR20050088079A (ko) 2002-11-15 2005-09-01 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
EP2319853B1 (en) * 2002-12-12 2014-03-12 IDENIX Pharmaceuticals, Inc. Process for the production of 2'-branched nucleosides
RU2005123395A (ru) * 2002-12-23 2006-01-27 Айденикс (Кайман) Лимитед (Ky) Способ получения 3-нуклеозидных пролекарств
US7429572B2 (en) 2003-05-30 2008-09-30 Pharmasset, Inc. Modified fluorinated nucleoside analogues
KR20070029196A (ko) 2004-06-08 2007-03-13 메타베이시스 테라퓨틱스, 인크. 고리 에스테르의 루이스 산 매개 합성
BRPI0512360A (pt) * 2004-06-23 2008-03-11 Idenix Cayman Ltd derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
WO2006031725A2 (en) 2004-09-14 2006-03-23 Pharmasset, Inc. Preparation of 2'­fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
CN103214483B (zh) 2005-12-13 2014-12-17 因塞特公司 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2，3-b]吡啶和吡咯并[2，3-b]嘧啶
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP1886998A1 (en) * 2006-08-09 2008-02-13 Esteve Quimica, S.A. Purification process of montelukast and its amine salts
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
EP2740731B1 (en) 2007-06-13 2016-03-23 Incyte Holdings Corporation Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
WO2009129120A2 (en) 2008-04-15 2009-10-22 Rfs Pharma, Llc Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
EP2376088B1 (en) 2008-12-23 2017-02-22 Gilead Pharmasset LLC 6-O-Substituted-2-amino-purine nucleoside phosphoramidates
EA019295B1 (ru) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Соединения пуриновых нуклеозидов и способ их получения
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
DK2432472T3 (da) 2009-05-22 2019-11-18 Incyte Holdings Corp 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer
TW201113285A (en) * 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
CN101792398B (zh) * 2010-03-09 2013-06-26 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
KR102283091B1 (ko) 2010-03-10 2021-07-30 인사이트 홀딩스 코포레이션 Ｊａｋ１ 저해제로서의 피페리딘­４­일 아제티딘 유도체
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
JP2013527145A (ja) 2010-03-31 2013-06-27 ギリード・ファーマセット・エルエルシー リン含有活性化剤の立体選択的合成
EP2574168B9 (en) 2010-05-21 2016-10-05 Incyte Holdings Corporation Topical formulation for a jak inhibitor
JP5917544B2 (ja) 2010-11-19 2016-05-18 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｊａｋ阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
AR083933A1 (es) 2010-11-19 2013-04-10 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
AR084044A1 (es) 2010-11-30 2013-04-17 Pharmasset Inc Compuestos 2’-espiro-nucleosidos
CN103797010B (zh) 2011-06-20 2016-02-24 因塞特控股公司 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US9193733B2 (en) 2012-05-18 2015-11-24 Incyte Holdings Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
CR20190073A (es) 2012-11-15 2019-04-25 Incyte Holdings Corp FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265)
CN103232491B (zh) * 2013-02-01 2016-06-15 河北科技大学 一种手性环磷酸的制备方法
RS62867B1 (sr) 2013-03-06 2022-02-28 Incyte Holdings Corp Postupci i intermedijeri za dobijanje inhibitora jak
EP3030227B1 (en) 2013-08-07 2020-04-08 Incyte Corporation Sustained release dosage forms for a jak1 inhibitor
PL3650014T3 (pl) 2013-08-27 2022-01-31 Gilead Pharmasset Llc Preparat złożony dwóch związków przeciwwirusowych
EP3105238A4 (en) 2014-02-13 2017-11-08 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
AR113922A1 (es) 2017-12-08 2020-07-01 Incyte Corp Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途
PE20211310A1 (es) 2018-01-30 2021-07-22 Incyte Corp Procedimiento para la elaboracion de un recipiente de vidrio de sosa-cal a partir de materiales formadores de vidrio 100% reciclados y un recipiente de vidrio elaborado a partir de dicho procedimiento
JP2021519775A (ja) 2018-03-30 2021-08-12 インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ Ｊａｋ阻害剤を用いる化膿性汗腺炎の治療
CN109485561A (zh) * 2018-11-23 2019-03-19 江苏颖盛化工有限公司 一种dl-萘普生的合成工艺
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT951631B (it) * 1971-03-18 1973-07-10 Richardson Merrell Spa Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.

Also Published As

Publication number Publication date
JPS61103886A (ja) 1986-05-22
ES8701187A1 (es) 1986-11-16
ES548135A0 (es) 1986-11-16
NL8403224A (nl) 1986-05-16
JPH0662652B2 (ja) 1994-08-17
DE3567022D1 (en) 1989-02-02
EP0180276A1 (en) 1986-05-07
ES554328A0 (es) 1987-04-01
US4814477A (en) 1989-03-21
EP0180276B1 (en) 1988-12-28

Similar Documents

Publication Publication Date Title
ES8704504A1 (es) Un procedimiento para preparar isomeros opticamente activos de dioxafosforinanos
ES8607969A1 (es) Un procedimiento para preparar un derivado de acido quinoli-no naftiridin- carboxilico
PT99556A (pt) Processo para a preparacao de novos compostos poliazamacrociclicos para a complexacao de metais
ES8700254A1 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
AU557959B2 (en) Aryl amides
ES8603490A1 (es) Un nuevo procedimiento para la preparacion de imidazorrifa- micinas
ES8506751A1 (es) Un procedimiento para preparar derivados de 5-halovinil-2'-desoxiuridina.
GB1496469A (en) N-(1,2,4-triazin-5-on-4-yl)-glycine derivatives process for their preparation and their use as herbicides
ES8401969A1 (es) Un procedimiento para la preparacion de una sal de amonio cuaternario.
ES8302093A1 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
FR2368495A1 (fr) Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues
ES445183A1 (es) Procedimiento para la obtencion del 4-acetamidofenil(+)-6- metoxi-alfa-metil-2-naftalenacetato.
ES8504703A1 (es) Un metodo para la preparacion de nuevos derivados de fenilbutilaldehido
ES8302005A1 (es) Procedimiento para preparar compuestos cefalosporanicos
ES8302703A1 (es) "un procedimiento para la preparacion de fenil-quinolicidinas".
ES477768A1 (es) Un procedimiento para la preparacion de 1 alfa-oxido de aci-do penicilinico.
ES8200877A2 (es) Procedimiento para la preparacion de nuevos derivados de 1- (3-(3,4,5-trimetoxifenoxi)-2-hidroxi-propil)-4-aril-pipera- zina
ES8206460A1 (es) Procedimiento para preparar formamidinas 3,3-disustituidas
ES8207183A1 (es) Un procedimiento para preparar compuestos de cefem .
ES8105967A1 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
ES8303428A1 (es) "un procedimiento para preparar nuevos compuestos de cefem".
ES8106515A1 (es) Procedimiento para la obtencion de un derivado de propileno
ES8302640A1 (es) Procedimiento para preparar derivados de benzoilurea
ES8102569A1 (es) Procedimiento de fabricar compuestos pirimidinicos con cabe-za de puente de nitrogeno
ES8205193A1 (es) Procedimiento para la obtencion de sales de acidos alcancar-boxilicos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203